Contact Us
Drug Search Results
More Filters [+]

Lulizumab pegol

Alternative Names: lulizumab pegol, bms-931699
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CD28 Inhibitor

Novel Mechanism: Yes

Modality: Antibody

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bristol-Myers Squibb
Company Location: NEW YORK NY 10016
Company CEO: Giovanni Caforio
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lulizumab pegol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Lupus Erythematosus, Systemic|Sjogren's Syndrome|Kidney Transplant|Renal Transplant

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
DAIT RTB-011

P2

Withdrawn

Renal Transplant|Kidney Transplant

2022-09-22

2014-002184-14

P2

Completed

Lupus Erythematosus, Systemic

2017-10-26

IM128-027

P2

Completed

Lupus Erythematosus, Systemic

2017-10-26

JapicCTI-153077

P2

Terminated

Lupus Erythematosus, Systemic

2017-10-01

Recent News Events

Date

Type

Title

02/01/2024

PubMed

 Model-based meta-analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus.

05/05/2023

PubMed

 CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant Survival.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions